The TME itself modulates Th17 plasticity, with chemokines such as CCL20, CCL17, and CCL22 recruiting Th17 cells, while tumor-derived cytokines such as IL-1β, IL-6, IL-23, and TGF-β promote their differentiation [186, 187]. This evidence concerns the gene IL1B and neoplasm.